Crossmark

Liraglutide improves metabolic parameters and carotid intima-media thickness in diabetic patients with the metabolic syndrome: an 18-month prospective study

Crossref DOI link: https://doi.org/10.1186/s12933-016-0480-8

Published Online: 2016-12-03

Published Print: 2016-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Rizzo, Manfredi

Rizvi, Ali A.

Patti, Angelo Maria

Nikolic, Dragana https://orcid.org/0000-0001-9572-9651
Giglio, Rosaria Vincenza

Castellino, Giuseppa

Li Volti, Giovanni

Caprio, Massimiliano

Montalto, Giuseppe

Provenzano, Vincenzo

Genovese, Stefano

Ceriello, Antonio
Clinical Trials ^BETA

Clinical trials referenced in this document:

nct01715428 at ClinicalTrials.gov

Documents that mention this clinical trial

Liraglutide Reduces Carotid Intima-Media Thickness by Reducing Small Dense Low-Density Lipoproteins in a Real-World Setting of Patients with Type 2 Diabetes: A Novel Anti-Atherogenic Effect
https://doi.org/10.1007/s13300-020-00962-3

Liraglutide improves metabolic parameters and carotid intima-media thickness in diabetic patients with the metabolic syndrome: an 18-month prospective study
https://doi.org/10.1186/s12933-016-0480-8
License Information

Text and Data Mining valid from 2016-12-01

Version of Record valid from 2016-12-03
More Information

Article History

Received: 6 September 2016

Accepted: 22 November 2016

First Online: 3 December 2016

Document is current

Any future updates will be listed below